Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel Diseases

Abstract

Background and Aims. Deoxyribonuclease I (DNaseI) is an endonuclease that facilitates chromatin breakdown and promotes susceptibility to autoimmune disorders. The aim of current study was to investigate serum DNase I activity in patients with inflammatory bowel diseases (IBD).Patients and Methods. A cohort of 110 IBD patients was evaluated, aged 35±12 years, 77 with Crohn's disease (CD) and 33 with ulcerative colitis (UC). 50 SLE patients and 50 healthy blood donors were examined as control groups.Results. DNase I activity in IBD patients was significantly lower than in healthy individuals, but higher than in SLE patients (P<.0001). Patients with UC showed higher DNase I activity than CD patients,P=.21. DNase I activity in female patients with IBD was significantly lower than in males,P=.024; however, no differences in DNase I activity were found in relation to gender in healthy individuals. DNase I activity has shown a strong negative correlation with the serum concentration of anti-nucleosomal antibodies in the autoimmune (SLE + IBD) cohort, as well as in the separate IBD cohort.Conclusions. Reduced serum DNase I activity probably has pathogenetic consequences in IBD. Induction of autoantibodies towards nucleosomes could be a reflection of impaired DNase I activity.